Exhibit 10.1


   


$10,000,000


 


Recon Technology Ltd.


 


Ordinary Shares


 


Equity Distribution Agreement


 


May 13, 2015


 


Maxim Group LLC

405 Lexington Avenue

New York, New York 10174


 


Ladies and Gentlemen:


 


Recon Technology Ltd., a corporation organized
under the laws of the Cayman Islands (the “Company”), proposes to issue and sell through Maxim Group
LLC (the “Agent”), as sales agent, ordinary shares of the Company, par value $0.0185 per share (the “Ordinary
Shares”), having an aggregate offering price of up to $10,000,000 (the “Shares”) on terms
set forth herein. The Shares consist entirely of authorized but unissued Ordinary Shares to be issued and sold by the Company.


 


The Company hereby confirms its agreement with
the Agent (this “Agreement”) with respect to the sale of the Shares.


 


1.          Representations
and Warranties of the Company.


 


(a)          The
Company represents and warrants to, and agrees with, the Agent as follows:


 




    	 



    	 



    

  


(i)          A
registration statement on Form S-3 (File No. 333-190387) (the “registration statement”) was initially
declared effective by the Securities and Exchange Commission (the “Commission”) on August 14, 2013, and
is currently effective, under the Securities Act of 1933, as amended (the “Securities Act of 1933”),
and the rules and regulations promulgated thereunder (the “Rules and Regulations” and collectively with
the Securities Act of 1933, the ”Securities Act”)); no additional or supplemental information was requested
by the Commission; no stop order of the Commission preventing or suspending the use of any Base Prospectus (as defined below),
the Prospectus Supplement (as defined below), the Prospectus (as defined below) or any Permitted Free Writing Prospectus (as defined
below), or the effectiveness of the Registration Statement, has been issued, and no proceedings for such purpose have been instituted
or, to the Company’s knowledge, are contemplated by the Commission. Except where the context otherwise requires, “Registration
Statement,” as used herein, means the registration statement, as amended at the time of such registration statement’s
effectiveness for purposes of Section 11 of the Securities Act, as such section applies to the Agent, including (1) all documents
filed as a part thereof or incorporated or deemed to be incorporated by reference therein, (2) any information contained or incorporated
by reference in a prospectus filed with the Commission pursuant to Rule 424(b) under the Securities Act, to the extent such information
is deemed, pursuant to Rule 430B or Rule 430C under the Securities Act, to be part of the registration statement at such time,
and (3) any registration statement filed to register the offer and sale of Shares pursuant to Rule 462(b) under the Securities
Act (the “462(b) Registration Statement”). Except where the context otherwise requires, “Base
Prospectus,” as used herein, means the prospectus filed as part of the Registration Statement, together with any
amendments or supplements thereto as of the date of this Agreement. Except where the context otherwise requires, “Prospectus
Supplement,” as used herein, means the most recent prospectus supplement relating to the Shares, filed by the Company
with the Commission pursuant to Rule 424(b) under the Securities Act and in accordance with the terms of this Agreement. Except
where the context otherwise requires, “Prospectus,” as used herein, means the Prospectus Supplement together
with the Base Prospectus attached to or used with the Prospectus Supplement, as may be amended or supplemented from time to time.
“Permitted Free Writing Prospectus,” as used herein, means the documents, if any, listed on Schedule
A attached hereto and, after the date hereof, any “issuer free writing prospectus” as defined in Rule 433 of the
Securities Act, that is expressly agreed to by the Company and the Agent in writing to be a Permitted Free Writing Prospectus.
Any reference herein to the Registration Statement, the Base Prospectus, the Prospectus Supplement, the Prospectus or any Permitted
Free Writing Prospectus shall be deemed to refer to and include the documents, if any, incorporated by reference, or deemed to
be incorporated by reference, therein pursuant to Item 12 of Form S-3 (the “Incorporated Documents”),
including, unless the context otherwise requires, the documents, if any, filed as exhibits to such Incorporated Documents. For
purposes of this Agreement, all references to the Registration Statement, the Rule 462(b) Registration Statement, the Base Prospectus,
the Prospectus or any amendment or supplement to any of the foregoing shall be deemed to include the copy filed with the Commission
pursuant to its Electronic Data Gathering, Analysis and Retrieval System (“EDGAR”). All references in
this Agreement to financial statements and schedules and other information which is “described,” “contained,”
“included” or “stated” in the Registration Statement, the Base Prospectus, the Prospectus or any Permitted
Free Writing Prospectus (or other references of like import) shall be deemed to mean and include all such financial statements
and schedules and other information which is incorporated by reference in or otherwise deemed by the Rules and Regulations to be
a part of or included in the Registration Statement, the Base Prospectus, the Prospectus or Permitted Free Writing Prospectus as
the case may be. Any reference herein to the terms “amend,” “amendment” or
“supplement” with respect to the Registration Statement, any Base Prospectus, the Prospectus, the Prospectus
Supplement or any Permitted Free Writing Prospectus shall be deemed to refer to and include the filing of any document under the
Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (collectively, the “Exchange
Act”) on or after the initial effective date of the Registration Statement, or the date of such Base Prospectus,
the Prospectus, the Prospectus Supplement or such Permitted Free Writing Prospectus, if any, as the case may be, and incorporated
or deemed to be incorporated therein by reference pursuant to Item 12 of Form S-3. “Time of Sale” means
each time a Share is purchased pursuant to this Agreement.


 




    	2



    	 



    

  


(ii)         (A)         The
Registration Statement complied when it became effective, complies as of the date hereof, and will comply upon the effectiveness
of any amendment thereto and at each Time of Sale and each Settlement Date (as applicable), in all material respects, with the
requirements of the Securities Act; at all times during which a prospectus is required by the Securities Act to be delivered (whether
physically or through compliance with Rule 172 under the Securities Act or any similar rule) in connection with any sale of Shares
(the “Prospectus Delivery Period”), the Registration Statement, as may be amended, will comply, in all
material respects, with the requirements of the Securities Act; the conditions to the use of Form S-3 in connection with the offering
and sale of the Shares as contemplated hereby (the “Offering”) have been satisfied, subject to the limitations
required by General Instruction I.B.6 of Form S-3; the Registration Statement meets, and the Offering complies with, the requirements
of Rule 415 under the Securities Act (including, without limitation, Rule 415(a)(5)); the Registration Statement did not, as of
the time of its effectiveness and as of the date hereof, and will not, as of the effective date of any amendment thereto, at each
Time of Sale, if any, and at all times during a Prospectus Delivery Period, contain an untrue statement of a material fact or omit
to state a material fact required to be stated therein or necessary to make the statements therein not misleading.


  


(B)         The
Prospectus, as of the date of the Prospectus Supplement, as of the date hereof (if filed with the Commission on or prior to the
date hereof), at each Settlement Date and Time of Sale (as applicable), and at all times during a Prospectus Delivery Period, complied,
complies or will comply, in all material respects, with the requirements of the Securities Act; and the Prospectus, and each supplement
thereto, as of their respective dates, at each Settlement Date or Time of Sale (as applicable), and at all times during a Prospectus
Delivery Period, did not and will not include an untrue statement of a material fact or omit to state a material fact necessary
in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.


 


(C)         Each
Permitted Free Writing Prospectus, if any, as of its date and as of each Settlement Date and Time of Sale (as applicable), and
at all times during a Prospectus Delivery Period (when taken together with the Prospectus at such time) will not include an untrue
statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of
the circumstances under which they were made, not misleading.


 


The representations and warranties set forth
in subparagraphs (A), (B) and (C) above shall not apply to any statement contained in the Registration Statement, any Base Prospectus,
the Prospectus or any Permitted Free Writing Prospectus in reliance upon and in conformity with information concerning the Agent
that is furnished in writing by or on behalf of the Agent expressly for use in the Registration Statement, such Base Prospectus,
the Prospectus or such Permitted Free Writing Prospectus, if any, it being understood and agreed that only such information furnished
by the Agent as of the date hereof consists of the information described in Section 6(b)(ii).


 




    	3



    	 



    

  


(iii)        Prior
to the execution of this Agreement, the Company has not, directly or indirectly, offered or sold any Shares by means of any “prospectus”
(within the meaning of the Securities Act) or used any “prospectus” (within the meaning of the Securities Act) in connection
with the Offering, in each case other than the Base Prospectus or any Permitted Free Writing Prospectus; the Company has not, directly
or indirectly, prepared, used or referred to any Permitted Free Writing Prospectus except in compliance with Rules 164 and 433
under the Securities Act; assuming that a Permitted Free Writing Prospectus, if any, is sent or given after the Registration Statement
was filed with the Commission (and after such Permitted Free Writing Prospectus, if any, was, if required pursuant to Rule 433(d)
under the Securities Act, filed with the Commission), the Company will satisfy the provisions of Rule 164 or Rule 433 necessary
for the use of a free writing prospectus (as defined in Rule 405) in connection with the Offering; the conditions set forth in
one or more of subclauses (i) through (iv), inclusive, of Rule 433(b)(1) under the Securities Act are satisfied, and the registration
statement relating to the Offering, as initially filed with the Commission, includes a prospectus that, other than by reason of
Rule 433 or Rule 431 under the Securities Act, satisfies the requirements of Section 10 of the Securities Act; neither the Company
nor the Agent is disqualified, by reason of subsection (f) or (g) of Rule 164 under the Securities Act, from using, in connection
with the Offering, “free writing prospectuses” (as defined in Rule 405 under the Securities Act) pursuant to Rules
164 and 433 under the Securities Act; the Company is not an “ineligible issuer” (as defined in Rule 405 under the Securities
Act) as of the eligibility determination date for purposes of Rules 164 and 433 under the Securities Act with respect to the offering
of the Shares contemplated by the Registration Statement; the parties hereto agree and understand that the content of any and all
“road shows” (as defined in Rule 433 under the Securities Act) related to the Offering is solely the property of the
Company.


 


(iv)        Each
Permitted Free Writing Prospectus, as of its issue date, each Time of Sale and each Settlement Date occurring after such issue
date and at all subsequent times through the Prospectus Delivery Period (as defined below) or until any earlier date that the Company
notified or notifies the Agent as described in Section 4(c)(iii), did not, does not and will not include any information
that conflicted, conflicts or will conflict with the information contained in the Registration Statement, any Base Prospectus or
the Prospectus. The foregoing sentence does not apply to statements in or omissions from any Permitted Free Writing Prospectus
based upon and in conformity with written information furnished to the Company by the Agent specifically for use therein, it being
understood and agreed that only such information furnished by the Agent as of the date hereof consist of the information described
in Section 6(b)(ii).


 


(v)         The
consolidated financial statements of the Company, the Subsidiaries (as defined below) and the VIEs (as defined below), together
with the related notes, set forth or incorporated by reference in the Registration Statement and the Prospectus comply in all material
respects with the requirements of the Securities Act and the Exchange Act and fairly present in all material respects the financial
condition of the Company, the Subsidiaries and the VIEs, as a whole, as of the dates indicated and the results of operations and
changes in cash flows for the periods therein specified in conformity with U.S. generally accepted accounting principles consistently
applied throughout the periods involved. No other financial statements or schedules are required to be included in the Registration
Statement and the Prospectus. To the Company’s knowledge, Friedman LLP, which has expressed its opinion with respect to the
financial statements and schedules, if any, filed as a part of the Registration Statement and included in the Registration Statement
and the Prospectus, is a registered public accounting firm within the meaning of the Securities Act and the Public Company Accounting
Oversight Board (“PCAOB”), and in the performance of its work for the Company has not been in violation
of the auditor independence requirements of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”).


 




    	4



    	 



    

  


(vi)        The
Company has been duly organized and is validly existing as a corporation under the laws of its jurisdiction of incorporation. The
Company, each of the Subsidiaries and each of the VIEs has full corporate power and authority to own its respective properties
and conduct its business as currently being carried on and as described in the Registration Statement and the Prospectus, and is
duly qualified to do business as a foreign corporation in good standing in each jurisdiction in which it owns or leases real property
or in which the conduct of its business makes such qualification necessary and in which the failure to so qualify would have a
material adverse effect upon the business, management, properties, operations, condition (financial or otherwise) or results of
operations of the Company, the Subsidiaries and the VIEs, taken as a whole (“Material Adverse Effect”).


 


(vii)       Except
as disclosed in the Prospectus, subsequent to the dates as of which information is given in the Prospectus, the Company (including
its Subsidiaries and the VIEs on a consolidated basis) have not incurred any material liabilities or obligations, direct or contingent,
or entered into any material transactions, or declared or paid any dividends or made any distribution of any kind with respect
to the capital stock of the Company; and there has not been any change in the capital stock of the Company, or issuance of options,
warrants, convertible securities or other rights to purchase the capital stock of the Company, or any material change in the short-term
or long-term debt of the Company (other than as a result of the exercise of any currently outstanding options or warrants that
are disclosed in the Prospectus), or any Material Adverse Effect or any development that would reasonably be expected to result
in a Material Adverse Effect.


 


(viii)      Except
as set forth in the Prospectus, there is no pending or, to the knowledge of the Company, threatened or contemplated, any action,
suit or proceeding to which the Company, any of its Subsidiaries or any of the VIEs is a party or of which any property or assets
of the Company, any of its Subsidiaries or any of the VIEs is the subject before or by any court or governmental agency, authority
or body, or any arbitrator or mediator, which, individually or in the aggregate, would reasonably be expected to result in any
Material Adverse Effect.


 


(ix)         There
are no statutes, regulations, contracts or documents that are required to be described in the Registration Statement and the Prospectus
or be filed as exhibits to the Registration Statement by the Securities Act that have not been so described or filed.


 


(x)          This
Agreement has been duly authorized, executed and delivered by the Company, and constitutes a valid, legal and binding obligation
of the Company, enforceable against the Company in accordance with its terms, except as rights to indemnity hereunder may be limited
by federal or state securities laws and except as such enforceability may be limited by bankruptcy, insolvency, reorganization
or similar laws affecting the rights of creditors generally and subject to general principles of equity. The execution, delivery
and performance of this Agreement and the consummation of the transactions herein contemplated will not result in a breach or violation
of any of the terms and provisions of, or constitute a default under, (i) any law, rule or regulation to which the Company, any
of its Subsidiaries or any of the VIEs is subject, (ii) any agreement or instrument to which the Company, any of its Subsidiaries
or any of the VIEs is a party or by which it is bound or to which any of its property is subject, (iii) the Company’s memorandum
of association or articles of association or the organizational documents of any of its Subsidiaries or any of the VIEs , or (iv)
any order, rule, regulation or decree of any court or governmental agency or body having jurisdiction over the Company, any of
its Subsidiaries or any of the VIEs or any of its properties, except, in the case of clauses (i), (ii) and (iv), for such breaches,
violations or defaults that would not reasonably be expected to result in a Material Adverse Effect.


 




    	5



    	 



    

  


(xi)         All
of the issued and outstanding shares of capital stock of the Company, including the outstanding Ordinary Shares, are duly authorized
and validly issued, fully paid and nonassessable, have been issued in compliance with all applicable foreign, federal and state
securities laws, were not issued in violation of or subject to any preemptive rights or other rights to subscribe for or purchase
securities that have not been waived in writing, and the holders thereof are not subject to personal liability by reason of being
such holders; all of the issued and outstanding shares of capital stock of each of the Subsidiaries and each of the VIEs are duly
authorized and validly issued, fully paid and nonassessable, have been issued in compliance with all applicable foreign, federal
and state securities laws, were not issued in violation of or subject to any preemptive rights or other rights to subscribe for
or purchase securities that have not been waived in writing, and the holders thereof are not subject to personal liability by reason
of being such holders; the Shares which may be sold under this Agreement by the Company have been duly authorized and, when issued,
delivered and paid for in accordance with the terms of this Agreement will have been validly issued and will be fully paid and
nonassessable, and the holders thereof will not be subject to personal liability solely by reason of being such holders; and the
capital stock of the Company, including the Common Stock, conforms in all material respects to the description thereof in the Registration
Statement and the Prospectus. Except as otherwise stated in the Registration Statement and the Prospectus, there are no preemptive
rights or other rights to subscribe for or to purchase, or any restriction upon the voting or transfer of, any shares of Common
Stock pursuant to the Company’s memorandum of association, articles of association or any agreement or other instrument to
which the Company is a party or by which the Company is bound. Neither the filing of the Registration Statement nor the Offering
gives rise to any rights for or relating to the registration of any shares of Common Stock or other securities of the Company,
except for such registration rights as have been duly waived. Except as described in the Registration Statement and the Prospectus,
there are no options, warrants, agreements, contracts or other rights in existence to purchase or acquire from the Company any
shares of the capital stock of the Company. The Company has an authorized and outstanding capitalization as set forth in the Registration
Statement and the Prospectus as of the dates set forth therein.


 


(xii)        The
Company, each of its Subsidiaries and each of the VIEs holds, and is operating in compliance with all grants, authorizations, licenses,
permits, consents, certificates and orders of any governmental or self-regulatory body required for the conduct of its respective
businesses and all such grants, authorizations, licenses, permits, consents, certifications and orders are valid and in full force
and effect, except for such noncompliance or failures to be in full force and effect that would not reasonably be expected to result
in a Material Adverse Effect; and neither the Company nor any of its Subsidiaries nor any of the VIEs has received notice of any
revocation or modification of any such grant, authorization, license, permit, consent, certification or order or has reason to
believe that any such grant, authorization, license, permit, consent, certification or order will not be renewed in the ordinary
course; and the Company, each of its Subsidiaries and each of the VIEs is in compliance with all applicable federal, state, local
and foreign laws, regulations, orders and decrees, except for such noncompliance that would not reasonably be expected to result
in a Material Adverse Effect. No approval, authorization, consent or order of or filing with any foreign, federal, state or local
governmental or regulatory commission, board, body, authority or agency is required in connection with the issuance and sale of
the Shares or the consummation by the Company of the transactions contemplated hereby, other than (i) registration of the Shares
under the Securities Act, (ii) any necessary qualification under the securities or blue sky laws of the various jurisdictions in
which the Shares are being offered by the Agent, (iii) the filing of any reports under the Exchange Act, (iv) such approvals as
may be required by the Conduct Rules of FINRA or (v) approval of the listing of the Shares by the NASDAQ Capital Market.


 




    	6



    	 



    

  


(xiii)       Except
as disclosed in the Registration Statement and the Prospectus, the Company, each of its Subsidiaries and each of the VIEs has good
and marketable title to all property (whether real or personal) described in the Registration Statement and the Prospectus as being
owned by it, in each case free and clear of all liens, claims, security interests, other encumbrances or defects except such as
are described in the Registration Statement and the Prospectus, except as would not materially impair the use or value thereof.
The property held under lease by the Company, each of its Subsidiaries and each of the VIEs is held by it under valid, subsisting
and enforceable leases with only such exceptions with respect to any particular lease as do not interfere in any material respect
with the conduct of the business of the Company, such Subsidiary or such VIE.


 


(xiv)      Except
as disclosed in the Registration Statement and the Prospectus, the Company, each of its Subsidiaries and each of the VIEs owns,
possesses, or can acquire on reasonable terms, all Intellectual Property (as defined below) necessary for the conduct of their
respective businesses as now conducted or as described in the Registration Statement and the Prospectus to be conducted. Except
as would not result in a Material Adverse Effect, (A) to knowledge of the Company, there are no rights of third parties to any
such Intellectual Property owned by the Company, except as otherwise disclosed to the Agent in writing by the Company prior to
the date hereof; (B) to the knowledge of the Company, there is no infringement, misappropriation or violation by third parties
of any such Intellectual Property; (C) there is no pending or, to the knowledge of the Company, threatened, action, suit, proceeding
or claim by others challenging the Company’s or any Subsidiary’s or any VIE’s rights in or to any such Intellectual
Property, and the Company is unaware of any facts which would form a reasonable basis for any such claim; (D) the Intellectual
Property owned by the Company, each of the Subsidiaries and each of the VIEs, and to the knowledge of the Company, the Intellectual
Property licensed to the Company, each of the Subsidiaries and each of the VIEs, has not been adjudged invalid or unenforceable,
in whole or in part, and there is no pending or, to the knowledge of the Company, threatened action, suit, proceeding or claim
by others challenging the validity or scope of any such Intellectual Property, and the Company is unaware of any facts which would
form a reasonable basis for any such claim; (E) there is no pending or, to the knowledge of the Company, threatened action, suit,
proceeding or claim by others that the Company, any of its Subsidiaries or any of the VIEs infringes, misappropriates or otherwise
violates any Intellectual Property or other proprietary rights of others, and neither the Company nor any of the Subsidiaries nor
any of the VIEs has received any written notice of such claim; and (F) to the Company’s knowledge, no employee of the Company
or any of its Subsidiaries nor any of the VIEs is in or has ever been in violation of any term of any employment contract, patent
disclosure agreement, invention assignment agreement, non-competition agreement, non-solicitation agreement, nondisclosure agreement
or any restrictive covenant to or with a former employer where the basis of such violation relates to such employee’s employment
with the Company or any of its Subsidiaries or any of the VIEs or actions undertaken by the employee while employed with the Company
or any of its Subsidiaries or any of the VIEs. “Intellectual Property” shall mean all patents, patent
applications, trade and service marks, trade and service mark registrations, trade names, copyrights, licenses, inventions, trade
secrets, domain names, technology, know-how and other intellectual property.


 




    	7



    	 



    

  


(xv)       Neither
the Company nor any of its Subsidiaries nor any of the VIEs is (A) in violation of its memorandum of association or articles of
association or similar organizational documents, or (B) in breach of or otherwise in default, and no event has occurred which,
with notice or lapse of time or both, would constitute such a default in the performance of any material obligation, agreement
or condition contained in any bond, debenture, note, indenture, loan agreement, mortgage, deed of trust or any other material contract,
lease or other instrument to which it is subject or by which any of them may be bound, or to which any of the material property
or assets of the Company, any of its Subsidiaries or any of the VIEs is subject (collectively, the “Material Contracts”);
or (C) in violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental
or regulatory authority, except in the case of (B) and (C) above, as could not, individually or in the aggregate, reasonably be
expected to result in a Material Adverse Effect.


 


(xvi)      Except
as disclose din the Registration Statement and the Prospectus, the Company, each of the Subsidiaries and each of the VIEs has timely
filed all applicable federal, state, local, foreign and other income and franchise tax returns required to be filed and are not
in default in the payment of any taxes which were payable pursuant to said returns or any assessments with respect thereto, other
than any which the Company, any of its Subsidiaries or any of the VIEs is contesting in good faith. There is no pending dispute
with any taxing authority relating to any of such returns, and the Company has no knowledge of any proposed liability for any tax
to be imposed upon the properties or assets of the Company or any of its Subsidiaries or any of the VIEs for which there is not
an adequate reserve reflected in the Company’s financial statements included in the Registration Statement.


 


(xvii)     The
Company has not distributed and will not distribute any prospectus or other offering material in connection with the Offering other
than any the Registration Statement and the Prospectus or other materials permitted by the Securities Act to be distributed by
the Company; provided, however, that the Company has not made and will not make any offer relating to the Shares that would constitute
a “free writing prospectus” as defined in Rule 405 under the Securities Act, except in accordance with the provisions
of Section 3(r) of this Agreement.


 


(xviii)    The
Ordinary Shares are registered pursuant to Section 12(b) of the Exchange Act and are listed on the NASDAQ Capital Market and the
Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Ordinary Shares under
the Exchange Act or delisting the Ordinary Shares from the NASDAQ Capital Market nor has the Company received any notification
that the Commission or the NASDAQ Capital Market is contemplating terminating such registration or listing. The Company has complied
in all material respects with the applicable requirements of the NASDAQ Capital Market for maintenance the listing of the Ordinary
Shares thereon. The Company has filed an application to include the Shares on the NASDAQ Capital Market.


 




    	8



    	 



    

  


(xix)       The
Company has no subsidiaries other than those listed on Schedule E hereto (collectively, the “Subsidiaries”).
Except as disclosed in the Registration Statement and the Prospectus, the Company does not own, directly or indirectly, any shares
of stock or any other equity or long-term debt securities of any other corporation or have any equity interest in any other corporation,
partnership, joint venture, association, trust or other entity.


 


(xx)        The
Company, each of its Subsidiaries and each of the VIEs have established and maintain systems of internal accounting controls sufficient
to provide reasonable assurances that (A) transactions are executed in accordance with management’s general or specific authorization;
(B) transactions are recorded as necessary to permit preparation of financial statements in conformity with generally accepted
accounting principles and to maintain accountability for assets; (C) access to assets is permitted only in accordance with management’s
general or specific authorization; and (D) amounts reflected on the Company’s consolidated balance sheet for assets are compared
with existing assets at reasonable intervals and appropriate action is taken with respect to any differences. Except as described
in the Registration Statement and the Prospectus, since the filing of the annual report on Form 10-K for the fiscal year ended
June 30, 2014, there has been (i) no new material weakness identified to the Company’s Board of Directors (or committee thereof)
in the Company’s internal control over financial reporting (whether or not remediated) and (ii) no change in the Company’s
internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s
internal control over financial reporting.


 


(xxi)       Except
as described in the Registration Statement and the Prospectus, the Company, each of the Subsidiaries and each of the VIEs: (A)
is and at all times since July 1, 2013 has been in material compliance with all United States (federal, state and local) and foreign
statutes, rules, regulations, treaties, or guidances applicable to Company, the Subsidiaries and the VIEs and to the ownership,
testing, development, manufacture, packaging, processing, use, distribution, marketing, labeling, promotion, sale, offer for sale,
storage, import, export or disposal of any product manufactured or distributed by the Company, any of its Subsidiaries or any of
the VIEs (“Applicable Laws”); (B) since July 1, 2013 has not received any notice of adverse finding,
warning letter, untitled letter or other correspondence or notice from any Governmental Authority (as defined below) alleging or
asserting noncompliance with any Applicable Laws or any licenses, certificates, approvals, clearances, authorizations, permits
and supplements or amendments thereto required by any such Applicable Laws (“Authorizations”); (C) since
July 1, 2013 has not received notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or
other action from any Governmental Authority or third party alleging that any product operation or activity is in violation of
any Applicable Laws or Authorizations and has no knowledge that any such Governmental Authority or third party intends to assert
any such claim, litigation, arbitration, action, suit, investigation or proceeding; (D) since July 1, 2013 has not received notice
that any Governmental Authority has taken, is taking or intends to take action to limit, suspend, modify or revoke any Authorizations
and the Company has no knowledge that any such Governmental Authority is considering such action; and (E) has filed, obtained,
maintained or submitted all material reports, documents, forms, notices, applications, records, claims, submissions and supplements
or amendments as required by any Applicable Laws or Authorizations and that all such reports, documents, forms, notices, applications,
records, claims, submissions and supplements or amendments were complete and correct in all material respects on the date filed
(or were corrected or supplemented by a subsequent submission) except for any of the foregoing that could not reasonably be expected
to have a Material Adverse Effect. “Governmental Authority” means any federal, provincial, state, local,
foreign or other governmental or quasi-governmental agency or body or any other type of regulatory authority or body, including,
without limitation, the NASDAQ Stock Market.


 




    	9



    	 



    

  


(xxii)      Other
than as contemplated by this Agreement, the Company has not incurred any liability for any finder’s or broker’s fee
or agent’s commission in connection with the execution and delivery of this Agreement or the consummation of the transactions
contemplated hereby.


 


(xxiii)     The
Company, each of the Subsidiaries and each of the VIEs carries, or is covered by, insurance in such amounts and covering such risks
the Company reasonably believes are adequate for the conduct of its respective business and the value of its properties and as
is customary for companies engaged in similar businesses in similar industries; all policies of insurance and any fidelity or surety
bonds insuring the Company, each of its Subsidiaries, each of the VIEs and their respective businesses, assets, employees, officers
and directors are in full force and effect; the Company, each of its Subsidiaries and each of the VIEs is in compliance with the
terms of such policies and instruments in all material respects; there are no claims by the Company, any of the Subsidiaries or
any of the VIEs under any such policy or instrument as to which any insurance company is denying liability or defending under a
reservation of rights clause; neither the Company nor any of the Subsidiaries nor any of the VIEs has been refused any insurance
coverage sought or applied for; and the Company has no reason to believe that it will not be able to renew its existing insurance
coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue
its business at a cost that would not have a Material Adverse Effect.


 


(xxiv)    The
Company is not, and, after giving effect to the Offering and the application of the proceeds thereof as described in the Prospectus,
will not be, an “investment company” as defined in the Investment Company Act of 1940, as amended.


 


(xxv)     The
Incorporated Documents, at the time they were or hereinafter are filed with the Commission, conformed and will conform in all material
respects to the requirements of the Securities Act and the Exchange Act, and were filed on a timely basis with the Commission and
no Incorporated Document contained or will contain an untrue statement of a material fact or omitted to state a material fact necessary
to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, that, no
representation is made herein regarding the representations, warranties and covenants, or any descriptions thereof, contained in
any agreements or documents included as exhibits to the Incorporated Documents. There is no material document required to be described
in the Registration Statement or the Prospectus or to be filed as an exhibit to the Registration Statement which was not described
or filed as required. All material agreements of the Company and all agreements governing or evidencing any and all related party
transactions have been filed with the Commission to the extent required and applicable under the Exchange Act.


 




    	10



    	 



    

  


(xxvi)    The
Company is in compliance in all material respects with all applicable provisions of the Sarbanes-Oxley Act and the rules and regulations
of the Commission thereunder.


 


(xxvii)   Except
as described in the Registration Statement and the Prospectus, the Company has established and maintains disclosure controls and
procedures (within the meaning of Rule 13a-15(e) of the Exchange Act) and such controls and procedures are designed to ensure that
information required to be disclosed in the reports that the Company files or submits under the Exchange Act is recorded, processed,
summarized and reported within the time periods specified in the rules and forms of the Commission and that such information is
accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer,
as appropriate, to allow timely decisions regarding required disclosure. The Company has utilized such controls and procedures
in preparing and evaluating the disclosures in the Registration Statement and the Prospectus.


 


(xxviii)    To
the knowledge of the Company, neither the Company, the Subsidiaries, the VIEs nor any director, officer, agent, employee or affiliate
of the Company, any Subsidiary or any VIE, has taken any action directly or indirectly, that would result in a violation by such
persons of the FCPA (as defined below), including, without limitation, making use of the mails or any means or instrumentality
of interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization of the payment of any money,
or other property, gift, promise to give, or authorization of the giving of anything of value to any “Foreign official”
(as such term is defined in the FCPA) or any foreign political party or official thereof or any candidate for foreign political
office, in contravention of the FCPA, and the Company, each of its Subsidiaries and each of the VIEs has conducted its business
in compliance with the FCPA and has instituted and maintains policies and procedures designed to ensure, and which are reasonably
expected to continue to ensure, continued compliance therewith. “FCPA” means the Foreign Corrupt Practices
Act of 1977, as amended, and the rules and regulations thereunder.


 


(xxix)      The
operations of the Company, each of its Subsidiaries and each of the VIEs have complied in all material respects with the money
laundering statutes of applicable jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations
or guidelines, issued, administered or enforced by applicable governmental agencies (collectively, the “Money Laundering
Laws”), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any
arbitrator involving the Company, any of its Subsidiaries or any of the VIEs with respect to the Money Laundering Laws is pending
or, to the knowledge of the Company, threatened.


 


(xxx)        Neither
the Company, any of its Subsidiaries, any of the VIEs, nor, to the knowledge of the Company, any director, officer, employee, representative,
agent, or affiliate of the Company, any of its Subsidiaries or any of the VIEs is currently subject to any U.S. sanctions administered
by the Office of Foreign Assets Control of the U.S. Department of the Treasury.


 




    	11



    	 



    

 


(xxxi)      No
transaction has occurred between or among the Company, any of its Subsidiaries or any of the VIEs on the one hand, and any officer,
director or 5% or greater stockholder of the Company, any Subsidiary of the Company or any of the VIEs or any affiliate or affiliates
of any such officer, director or 5% or greater stockholder that is required to be described that is not so described in the Registration
Statement and the Prospectus. Neither the Company nor any of its Subsidiaries nor any of the VIEs has, directly or indirectly,
extended or maintained credit, or arranged for the extension of credit, or renewed an extension of credit, in the form of a personal
loan to or for any of its directors or executive officers in violation of applicable laws, including Section 402 of the Sarbanes-Oxley
Act.


 


(xxxii)     The
Company, each of its Subsidiaries and each of the VIEs (A) is in compliance in all material respects with all applicable federal,
state, local and foreign laws, rules, regulations relating to the protection of human health and safety, the environment or hazardous
or toxic substances or wastes, pollutants or contaminants (collectively, “Environmental Laws”); (B) has
received and is in compliance in all material respects with all permits, licenses or other approvals required of it under applicable
Environmental Laws to conduct its business; and (C) has not received notice of any actual or potential liability for the investigation
or remediation of any disposal or release of hazardous or toxic substances or wastes, pollutants or contaminants. No action, proceeding,
revocation proceeding, writ, injunction or claim is pending or, to the Company’s knowledge, threatened against the Company,
any of its Subsidiaries or any of the VIEs relating to Environmental Laws, and the Company does not have knowledge of any facts,
circumstances or developments relating to its operations or cost accounting practices that could reasonably be expected to form
the basis for or give rise to such actions, suits, investigations or proceedings.


 


(xxxiii)    The
Company, each of the Subsidiaries and each of the VIEs (A) is in compliance, in all material respects, with applicable foreign,
federal, state and local laws, rules, regulations, statutes and codes promulgated by applicable governmental authorities (including
pursuant to the Occupational Health and Safety Act) relating to the protection of human health and safety in the workplace (“Occupational
Laws”); (B) has received all material permits, licenses or other approvals required of it under applicable Occupational
Laws to conduct its business as currently conducted; and (C) is in compliance, in all material respects, with all terms and conditions
of such permit, license or approval. No action, proceeding, revocation proceeding, writ, injunction or claim is pending or, to
the Company’s knowledge, threatened against the Company, any of its Subsidiaries or any of the VIEs relating to Occupational
Laws, and the Company does not have knowledge of any facts, circumstances or developments relating to its operations or cost accounting
practices that could reasonably be expected to form the basis for or give rise to such actions, suits, investigations or proceedings.


 


(xxxiv)     No
material labor problem or dispute with the employees of the Company, any of its Subsidiaries or any of the VIEs exists or, to the
knowledge of the Company, is threatened or imminent.


 


(xxxv)      The
Company has not taken, directly or indirectly, any action designed to or that would constitute or that would reasonably be expected
to cause or result in, under the Exchange Act or otherwise, stabilization or manipulation of the price of any security of the Company
to facilitate the sale or resale of the Shares.


 




    	12



    	 



    

 


(xxxvi)     Other
than the Agent, no person or entity has the right to act as a placement agent, underwriter or as a financial advisor in connection
with the sale of the Shares contemplated hereby, and the Company is not a party to any agreement with an agent or underwriter for
any other “at-the-market” or continuous equity transaction.


 


(xxxvii)    There
is no transaction, arrangement or other relationship between the Company, any of its Subsidiaries or any of the VIEs and an unconsolidated
or other off balance sheet entity that is required to be disclosed by the Company in the Registration Statement or the Prospectus
and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.


 


(xxxviii)    None
of the Company, its Subsidiaries, the VIEs or any of their respective affiliates, nor any person or entity acting on their behalf
(excluding the Agent) has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any
security, under circumstances that would cause the transactions contemplated by this Agreement to require approval of stockholders
of the Company under any applicable stockholder approval provisions, including, without limitation, under the rules and regulations
of the NASDAQ Capital Market. None of the Company, its Subsidiaries, their affiliates nor any person or entity acting on their
behalf will take any action or steps that would cause the offering of any of the Shares to be integrated with other offerings of
securities of the Company.


 


(b)          Any
certificate signed by any officer of the Company and delivered to the Agent or the Agent’s counsel shall be deemed a representation
and warranty by the Company to Agent as to the matters covered thereby.


 


(c)          At
each Bringdown Date and each Time of Sale, the Company shall be deemed to have affirmed each representation and warranty contained
in or made pursuant to this Agreement as of such date as though made at and as of such date (except that such representations and
warranties shall be deemed to relate to the Registration Statement and the Prospectus as amended and supplemented relating to such
Shares on such date).


 


2.           Representations
and Warranties of the Company as to PRC Matters


 


(a)          The
Company conducts substantially all of its operations and generates substantially all of its revenue through (1) Recon Technology
(Jining) Co., Ltd, a wholly foreign-owned enterprise formed under the laws of the People's Republic of China (the "PRC")
(the "PRC Subsidiary") and (2) the companies formed under the laws of the PRC (the "VIEs") indicated
as VIEs on Schedule E hereof. The PRC Subsidiary and the VIEs are collectively referred to hereinafter as the "PRC Entities."


 




    	13



    	 



    




 


(b)          Each
of the PRC Entities has been duly established, is validly existing as a company in good standing under the laws of the PRC, has
the corporate power and authority to own, lease and operate its property and to conduct its business as described in the Registration
Statement and the Prospectus, and is duly qualified to transact business and is in good standing in each jurisdiction in which
the conduct of its business or its ownership or leasing of property requires such qualification, except to the extent that the
failure to be so qualified or be in good standing would not, singly or in the aggregate, have a Material Adverse Effect. Each PRC
Entity has applied for and obtained all requisite business licenses, clearance and permits required under PRC law as necessary
for the conduct of its businesses, and each PRC Entity has complied in all material respects with all PRC laws in connection with
foreign exchange, including without limitation, carrying out all relevant filings, registrations and applications for relevant
permits with the PRC State Administration of Foreign Exchange and any other relevant authorities, and all such permits are validly
subsisting. The registered capital of each PRC Entity has been fully paid up in accordance with the schedule of payment stipulated
in its respective articles of association, approval document, certificate of approval and legal person business license (hereinafter
referred to as the "Establishment Documents") and in compliance with PRC laws and regulations, and there is no
outstanding capital contribution commitment for any PRC Entity. The Establishment Documents of the PRC Entities have been duly
approved in accordance with the laws of the PRC and are valid and enforceable. The business scope specified in the Establishment
Documents of each PRC Entity complies with the requirements of all relevant PRC laws and regulations. The outstanding equity interests
of each PRC Entity is owned of record by the respective entities or individuals identified as the registered holders thereof in
the Registration Statement and the Prospectus.


 


(c)          Except
as disclosed in the Registration Statement and the Prospectus, no consents, approvals, authorizations, orders, registrations, clearances,
certificates, franchises, licenses, permits or qualifications of or with any PRC governmental agency are required for the Company's
or its Subsidiaries' contractual arrangements and agreements with the VIEs and their registered equity holders (the "VIE
Structure") or the execution, delivery and performance of such contractual arrangements and agreements (the "VIE
Structuring Documents"). None of the VIE Structuring Documents has been revoked and no such revocation is pending or threatened.
Each of the VIE Structuring Documents has been entered into prior to the date thereof in compliance with all applicable laws and
regulations and constitutes a valid and legally binding agreement, enforceable in accordance with its terms.


 


(d)          The
VIE Structure and the execution, delivery and performance of the VIE Structuring Documents and the consummation of the transactions
contemplated thereby did not and do not (i) conflict with, or result in a breach or violation of any of the terms and provisions
of, or constitute a default under, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which
any PRC Entity is a party or by which any PRC Entity is bound or by which any of the properties or assets of any PRC Entity is
subject, (ii) violate or conflict with the Establishment Documents of any PRC Entity, or (iii) violate or conflict with any applicable
laws, regulations, rules, orders, decrees, guidelines, notices or other legislation of the PRC.


 


(e)          The
VIE Structure complies, and after the consummation of the Offering and sale of the Shares will comply, with all applicable laws,
regulations, rules, orders, decrees, guidelines, notices or other legislation of the PRC; the VIE Structure has not been challenged
by any PRC governmental agency and there are no legal, arbitration, governmental or other proceedings (including, without limitation,
governmental investigations or inquiries) pending before or, to the Company's knowledge, threatened or contemplated by any PRC
governmental agency in respect of the VIE Structure.


 




    	14



    	 



    

 


(f)          The
Company possesses, directly or indirectly, the power to direct, or cause the direction of, the management and policies of each
of the VIEs.


 


(g)          The
PRC Subsidiary is not currently prohibited, directly or indirectly, from paying any dividends to the Company (or the Company's
Subsidiary that holds the outstanding equity interest of such PRC Subsidiary), and no VIE is currently prohibited, directly or
indirectly, from paying any of its obligations set forth in the VIE Structuring Documents. Except as disclosed in the Registration
Statement and the Prospectus, no PRC Entity is prohibited or restricted, directly or indirectly, from making any other distribution
on such PRC Entity's equity capital, or from repaying to the Company any loans or advances to such PRC Entity made by the Company
or any of its Subsidiaries.


 


(h)          The
choice of the laws of the State of New York as the governing law of this Agreement is a valid choice of law under the laws of the
PRC and will be honored by courts in the PRC.


 


(i)          None
of the PRC Entities nor any of their properties, assets or revenues are entitled to any right of immunity on the grounds of sovereignty
from any legal action, suit or proceeding, from set-off or counterclaim, from the jurisdiction of any court, from services of process,
from attachment prior to or in aid of execution of judgment, or from any other legal process or proceeding for the giving of any
relief or for the enforcement of any judgment.


 


(j)          It
is not necessary that this Agreement, the Registration Statement, the Prospectus or any other document be filed or recorded with
any governmental agency, court or other authority in the PRC.


 


(k)          No
transaction, stamp, capital or other issuance, registration, transaction, transfer or withholding taxes or duties are payable in
the PRC by or on behalf of the Agent to any PRC taxing authority in connection with (i) the issuance, sale and delivery of the
Shares by the Company or (ii) the execution and delivery of this Agreement and the consummation of the transactions contemplated
hereby.


 


(l)          The
Company has taken all necessary steps to comply with, and to ensure compliance by all of the Company's direct or indirect shareholders
and option holders who are PRC residents with, any applicable rules and regulations of the PRC State Administration of Foreign
Exchange of the PRC (the "SAFE Rules and Regulations"), including, without limitation, requiring each shareholder
and option holder that is, or is directly or indirectly owned or controlled by, a PRC resident to complete any registration and
other procedures required under applicable SAFE Rules and Regulations.


 




    	15



    	 



    

 


(m)          The
Company is aware of, and has been advised as to, the content of the Rules on Mergers and Acquisitions of Domestic Enterprises by
Foreign Investors jointly promulgated on August 8, 2006 by the PRC Ministry of Commerce, the PRC State Assets Supervision and Administration
Commission, the PRC State Administration of Taxation, the PRC State Administration of Industry and Commerce, the China Securities
Regulatory Commission ("CSRC") and the PRC State Administration of Foreign Exchange of the PRC and amended by
PRC Ministry of Commerce on June 22, 2009 (the "M&A Rules"), in particular the relevant provisions thereof
that purport to require offshore special purpose vehicles controlled directly or indirectly by PRC-incorporated companies or PRC
residents and established for the purpose of obtaining a stock exchange listing outside of the PRC to obtain the approval of the
CSRC prior to the listing and trading of their securities on any stock exchange located outside of the PRC. The Company has received
legal advice specifically with respect to the M&A Rules from its PRC counsel and the Company understands such legal advice.
In addition, the Company has communicated such legal advice in full to each of its directors that signed the Registration Statements
and each such director has confirmed that he or she understands such legal advice.


 


(n)          The
issuance and sale of the Shares, the listing and trading of the Shares on the Exchange and the consummation of the transactions
contemplated by this Agreement, the Registration Statement and the Prospectus are not and will not be, as of the date hereof and
on each Settlement Date, prohibited or otherwise affected by the M&A Rules or any official clarifications, guidance, interpretations
or implementation rules in connection with or related to the M&A Rules.


 


(o)          The
Company has taken all necessary steps to ensure compliance by each of its shareholders, option holders, directors, officers and
employees that is, or is directly or indirectly owned or controlled by, a PRC resident or citizen with any applicable rules and
regulations of the relevant PRC government agencies (including but not limited to the PRC Ministry of Commerce, the PRC National
Development and Reform Commission and the PRC State Administration of Foreign Exchange) relating to overseas investment by PRC
residents and citizens (the "PRC Overseas Investment and Listing Regulations"), including, requesting each shareholder,
option holder, director, officer, employee and participant that is, or is directly or indirectly owned or controlled by, a PRC
resident or citizen to complete any registration and other procedures required under applicable PRC Overseas Investment and Listing
Regulations.


 


(p)          As
of the date hereof, the M&A Rules and Related Clarifications do not require the Company to obtain the approval of the CSRC
prior to the issuance and sale of the Shares, the listing and trading of the Shares on the Nasdaq Capital Market, or the consummation
of the transactions contemplated by this Agreement, the Registration Statement, or the Prospectus.


 


(q)          Each
of the PRC Entities is in compliance with all requirements under all applicable PRC laws and regulations to qualify for their exemptions
from enterprise income tax or other income tax benefits (the "Tax Benefits") as described in the Registration
Statement and the Prospectus, and the actual operations and business activities of each such PRC Entity are sufficient to meet
the qualifications for the Tax Benefits. No submissions made to any PRC government authority in connection with obtaining the Tax
Benefits contained any misstatement or omission that would have affected the granting of the Tax Benefits. No PRC Entity has received
notice of any deficiency in its respective applications for the Tax Benefits, and the Company is not aware of any reason why any
such PRC Entity might not qualify for, or be in compliance with the requirements for, the Tax Benefits.


 




    	16



    	 



    

 


(r)          All
local and national PRC governmental tax holidays, exemptions, waivers, financial subsidies, and other local and national PRC tax
relief, concessions and preferential treatment enjoyed by any PRC Entity as described in the Registration Statement and the Prospectus
are valid, binding and enforceable and do not violate any laws, regulations, rules, orders, decrees, guidelines, judicial interpretations,
notices or other legislation of the PRC.


 


(s)          The
Agent will not be deemed to be resident, domiciled, carrying on business or subject to taxation in the PRC solely by reason of
its execution, delivery, performance or enforcement of, or the consummation of any transaction contemplated by this Agreement,
the Registration Statement or the Prospectus.


 


3.           Purchase,
Sale and Delivery of Shares.


 


(a)          At
the Market Sales. On the basis of the representations, warranties and agreements herein the Company agrees that, from time
to time during the term of this Agreement, on the terms and subject to the conditions set forth herein, it may issue and sell through
the Agent, acting as sales agent, the Shares up to an aggregate offering price of $10,000,000 (the “Maximum Amount”)
subject to the limitations required by General Instruction I.B.6 of Form S¬3. Notwithstanding the foregoing, the Company agrees
that it will provide the Agent with written notice no less than ten (10) business days prior to the date on which it makes the
initial sale of Shares under this Agreement.


 


(i)          Each
time the Company wishes to issue and sell the Shares hereunder (each, a “Transaction”), it will notify
the Agent by telephone (confirmed promptly by facsimile or e-mail to the appropriate individual listed on Schedule D hereto,
using a form substantially similar to that set forth on Schedule C hereto (a “Transaction Notice”)
as to the maximum number of Shares to be sold by the Agent on such day and in any event not in excess of the amount available for
issuance under the Prospectus and the currently effective Registration Statement, the time period during which sales are requested
to be made, any limitation on the number of shares that may be sold in any one Trading Day (as defined below), and any minimum
price below which sales may not be made. The Transaction Notice shall originate from any of the individuals from the Company set
forth on Schedule B (with a copy to each of the other individuals from the Company listed on such Schedule), and shall be
addressed to each of the individuals from the Agent set forth on Schedule D, as such Schedule D may be amended from
time to time. Subject to the terms and conditions hereof and unless the sale of the Shares described therein has been declined,
suspended, or otherwise terminated in accordance with the terms of this Agreement, the Agent shall promptly acknowledge the Transaction
Notice by facsimile or e-mail (or by some other method mutually agreed to in writing by the parties) and shall use its commercially
reasonable efforts to sell all of the Shares so designated by the Company in the Transaction Notice; provided, however, that any
obligation of the Agent to use such commercially reasonable efforts shall be subject to the continuing accuracy of the representations
and warranties of the Company herein, to the performance by the Company of its obligations hereunder and to the continuing satisfaction
of the additional conditions specified in Section 5 of this Agreement. The gross sales price of the Shares sold under this
Section 3(a) shall be equal to the market price for the Company’s Ordinary Shares sold by the Agent under this Section
3(a) on the NASDAQ Capital Market at the time of such sale. For the purposes hereof, “Trading Day”
means any day on which Ordinary Shares are purchased and sold on the principal market on which the Ordinary Shares are listed or
quoted.


 




    	17



    	 



    

 


(ii)         The
Company or the Agent may, upon notice to the other party hereto by telephone (confirmed promptly by facsimile or e-mail to the
respective individuals of the other party set forth on Schedule D hereto, which confirmation shall be promptly acknowledged
by the other party), suspend the Offering for any reason and at any time, whereupon the Agent shall so suspend the offering of
Shares until further notice is provided by the other party to the contrary; provided, however, that such suspension
or termination shall not affect or impair the parties’ respective obligations with respect to the Shares sold hereunder prior
to the receipt by the Agent of such notice. Each of the parties agrees that no such notice under this Section 3(a)(ii) shall
be effective against the other unless it is made to one of the individuals named on Schedule D hereto, as such Schedule
may be amended from time to time. Notwithstanding the foregoing, if the Agent suspends the Offering for any three consecutive business
days or on more than three (3) separate occasions (in each instance other than as a result of the Company’s breach of its
obligations hereunder), the Company, in its sole discretion, may elect to terminate this Agreement, and shall not be liable to
the Agent for any fees payable under Section 4(g) hereunder other than pursuant to the last three sentences thereof.


 


(iii)        The
Company acknowledges and agrees that (A) there can be no assurance that the Agent will be successful in selling the Shares, (B)
the Agent will incur no liability or obligation to the Company or any other person or entity if it does not sell Shares for any
reason other than a failure by the Agent to use its commercially reasonable efforts consistent with its normal trading and sales
practices and applicable law and regulations to sell such Shares as required under this Agreement, and (C) the Agent shall be under
no obligation to purchase shares on a principal basis pursuant to this Agreement.


 


(iv)        The
Agent hereby covenants and agrees not to make any sales of the Shares on behalf of the Company, pursuant to this Section 3(a),
other than by means of ordinary brokers’ transactions deemed to be “at the market” offerings as defined in Rule
415 of the Securities Act including without limitation sales made directly on the NASDAQ Capital Market, on any other existing
trading market for the Ordinary Shares or to or through a market maker. The Agent may also sell Shares in privately negotiated
transactions.


 


(v)         The
compensation to the Agent for sales of the Shares, as an agent of the Company, shall be 3.5% of the gross sales price of all of
Shares sold pursuant to this Section 3(a). The remaining proceeds, after further deduction for any transaction fees imposed
by any governmental or self-regulatory organization in respect of such sales, shall constitute the net proceeds to the Company
for such Shares (the “Net Proceeds”). The Agent shall notify the Company as promptly as practicable if
any deduction referenced in the preceding sentence will be required.


 


(vi)        The
Agent shall provide written confirmation to the Company following the close of trading on the NASDAQ Capital Market each day in
which the Shares are sold under this Section 3(a) setting forth the number of the Shares sold on such day, the aggregate
gross sale proceeds, the Net Proceeds to the Company, and the compensation payable by the Company to the Agent with respect to
such sales.


 




    	18



    	 



    

 


(vii)       All
Shares sold pursuant to this Section 3(a) will be delivered by the Company to Agent for the accounts of the Agent on the
third full business day following the date on which such Shares are sold, or at such other time and date as Agent and the Company
determine pursuant to Rule 15c6-1(a) under the Exchange Act, each such time and date of delivery being herein referred to as a
“Settlement Date.” On each Settlement Date, the Shares sold through the Agent for settlement on such
date shall be issued and delivered by the Company to the Agent against payment of the Net Proceeds from the sale of such Shares.
Settlement for all such Shares shall be effected by free delivery of the Shares by the Company or its transfer agent (i) to the
Agent or its designee’s account (provided the Agent shall have given the Company written notice of such designee prior to
the Settlement Date) at The Depository Trust Company (“DTC”) or (ii) by such other means of delivery
as may be mutually agreed upon by the parties hereto, which in all cases shall be freely tradable, transferable, registered shares
in good deliverable form, in return for payment in same day funds delivered to an account designated by the Company. If the Company
or its transfer agent (if applicable) shall default on its obligation to deliver the Shares on any Settlement Date, the Company
shall (A) indemnify and hold the Agent harmless against any loss, claim or damage arising from or as a result of such default by
the Company and (B) pay the Agent any commission to which it would otherwise be entitled absent such default against payment of
the Net Proceeds therefor by wire transfer of same day funds payable to the order of the Company at 9:00 a.m. New York City time.
If the Agent breaches this Agreement by failing to deliver the Net Proceeds on any Settlement Date for the shares delivered by
the Company, the Agent will pay the Company interest based on the effective prime rate until such proceeds, together with such
interest, have been fully paid.


 


(viii)      Under
no circumstances shall the Company cause or request the offer or sale of any Shares if, after giving effect to the sale of such
Shares, (i) the aggregate gross sales proceeds sold pursuant to this Agreement would exceed the lesser of (A) together with all
sales of Shares under this Agreement, the Maximum Amount, (B) the amount available for offer and sale under the currently effective
Registration Statement and (C) the amount authorized from time to time to be issued and sold under this Agreement by the Company’s
board of directors, a duly authorized committee thereof or a duly authorized executive committee, and notified to the Agent in
writing or (ii) the total amount of Ordinary Shares outstanding would exceed the number of Ordinary Shares authorized by the Company’s
memorandum of association and articles of association. Under no circumstances shall the Company cause or request the offer or sale
of any Shares at a price lower than the minimum price authorized from time to time by the Company’s board of directors, duly
authorized committee thereof or a duly authorized executive committee, and notified to the Agent in writing. Further, under no
circumstances shall the aggregate offering amount of Shares sold pursuant to this Agreement, including any separate underwriting
or similar agreement covering principal transactions, exceed the Maximum Amount.


 


(ix)         The
Company agrees that any offer to sell, any solicitation of an offer to buy, or any sales of Shares shall only be effected by or
through the Agent; provided, however, that the foregoing limitation shall not apply to the exercise of any outstanding option or
warrant described in the Registration Statement and the Prospectus.


 


(b)          Nothing
herein contained shall constitute the Agent an unincorporated association or partner with the Company. Under no circumstances shall
any Shares be sold pursuant to this Agreement after the date which is three years after the Registration Statement is first declared
effective by the Commission.


 




    	19



    	 



    

 


(c)          Notwithstanding
any other provisions of this Agreement, the Company agrees that no sale of Shares shall take place, and the Company shall not request
the sale of any Shares, and the Agent shall not be obligated to sell, during any period in which the Company is, or could be deemed
to be, in possession of material non-public information or the Company’s insider trading policy would prohibit the purchase
and sale of the Company’s Ordinary Shares by it officers and directors.


 


4.           Covenants.
The Company covenants and agrees with the Agent as follows:


 


(a)          After
the date hereof and through any Prospectus Delivery Period, prior to amending or supplementing the Registration Statement (including
any Rule 462(b) Registration Statement), Base Prospectus, the Prospectus or any Permitted Free Writing Prospectus, the Company
shall furnish to the Agent for review a copy of each such proposed amendment or supplement, allow the Agent a reasonable amount
of time to review and comment on such proposed amendment or supplement, and the Company shall not file any such proposed amendment
or supplement to which the Agent or counsel to the Agent reasonably object; provided that the foregoing shall not apply with regards
to the filing by the Company of any Form 10-K, 10-Q, 8-K, proxy statement or other Incorporated Document. Subject to this Section
4(a), immediately following execution of this Agreement, the Company will prepare a prospectus supplement describing the selling
terms of the Shares hereunder, the plan of distribution thereof and such other information as may be required by the Securities
Act or the Rules and Regulations or as the Agent and the Company may deem appropriate, and if requested by the Agent, a Permitted
Free Writing Prospectus containing the selling terms of the Shares hereunder and such other information as the Company and the
Agent may deem appropriate, and will file or transmit for filing with the Commission, in accordance with Rule 424(b) or Rule 433,
as the case may be, copies of the Prospectus as supplemented and each such Permitted Free Writing Prospectus.


 


(b)          After
the date of this Agreement, the Company shall promptly advise the Agent in writing (i) of the receipt of any comments of, or requests
for additional or supplemental information from, the Commission or for any amendments or supplements to the Registration Statement,
the Base Prospectus, the Prospectus or any Permitted Free Writing Prospectus (excluding any Incorporated Documents), (ii) of the
time and date of any filing of any post-effective amendment to the Registration Statement or any amendment or supplement to any
Base Prospectus, the Prospectus or any Permitted Free Writing Prospectus(excluding any Incorporated Documents), (iii) of the time
and date that any post-effective amendment to the Registration Statement becomes effective, (iv) of the issuance by the Commission
of any stop order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto or of any
order preventing or suspending its use or the use of any Base Prospectus, the Prospectus or any Permitted Free Writing Prospectus,
or (v) of any proceedings to remove, suspend or terminate from listing or quotation the Ordinary Shares from any securities exchange
upon which it is listed for trading or included or designated for quotation, or of the threatening or initiation of any proceedings
for any of such purposes. If the Commission shall enter any such stop order at any time, the Company may terminate this Agreement.
Additionally, the Company agrees that it shall comply with the provisions of Rules 424(b), 430B and 430C, as applicable, under
the Securities Act and will use its reasonable efforts to confirm that any filings made by the Company under Rule 424(b), Rule
433 or Rule 462 were received in a timely manner by the Commission (without reliance on Rule 424(b)(8) or Rule 164(b)).


 




    	20



    	 



    

 


(c)          (i)          From
the date hereof through the later of (A) the termination of this Agreement and (B) the end of any applicable Prospectus Delivery
Period, the Company will comply with all requirements imposed upon it by the Securities Act, as now and hereafter amended, and
by the Rules and Regulations, as from time to time in force, and by the Exchange Act so far as necessary to permit the continuance
of sales of or dealings in the Shares as contemplated by the provisions hereof, the Base Prospectus, the Prospectus and any Permitted
Free Writing Prospectus. If during any applicable Prospectus Delivery Period any event occurs as a result of which the Base Prospectus,
the Prospectus, or any Permitted Free Writing Prospectus would include an untrue statement of a material fact or omit to state
a material fact necessary to make the statements therein, in the light of the circumstances then existing, not misleading, or if
during any applicable Prospectus Delivery Period it is necessary or appropriate in the opinion of the Company or its counsel or
in the reasonable opinion of the Agent or counsel to the Agent to amend the Registration Statement or supplement the Base Prospectus,
the Prospectus or any Permitted Free Writing Prospectus, to comply with the Securities Act or to file under the Exchange Act any
document which would be deemed to be incorporated by reference in the Prospectus in order to comply with the Securities Act or
the Exchange Act, the Company will promptly notify Agent (or the Agent will notify the Company, as applicable), and the Agent shall
suspend the offering and sale of any such Shares, and the Company will amend the Registration Statement or supplement the Base
Prospectus, the Prospectus or any Permitted Free Writing Prospectus or file such document (at the expense of the Company) so as
to correct such statement or omission or effect such compliance within the time period prescribed by the Securities Act or the
Exchange Act.


 


(ii)         In
case the Agent is required to deliver (whether physically or through compliance with Rule 172 under the Securities Act or any similar
rule), in connection with the sale of the Shares, a Prospectus after the nine-month period referred to in Section 10(a)(3) of the
Securities Act, or after the time a post-effective amendment to the Registration Statement is required pursuant to Item 512(a)
of Regulation S-K under the Securities Act, the Company will prepare, at its expense, promptly upon request such amendment or amendments
to the Registration Statement and the Prospectus as may be necessary to permit compliance with the requirements of Section 10(a)(3)
of the Securities Act or Item 512(a) of Regulation S-K under the Securities Act, as the case may be. The Company shall cause each
amendment or supplement to any Base Prospectus or the Prospectus to be filed with the Commission as required pursuant to the applicable
paragraph of Rule 424(b) of the Securities Act or, in the case of any document which would be deemed to be incorporated by reference
therein, to be filed with the Commission as required pursuant to the Exchange Act, within the time period prescribed. The Company
shall promptly notify the Agent if any Material Contract is terminated or if the other party thereto gives written notice of its
intent to terminate any such Material Contract.


 


(iii)        If
at any time following issuance of a Permitted Free Writing Prospectus there occurs an event or development as a result of which
such Permitted Free Writing Prospectus would conflict with the information contained in the Registration Statement, the Base Prospectus
or the Prospectus, or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary
in order to make the statements therein, in the light of the circumstances prevailing at that subsequent time, not misleading,
the Company promptly will notify the Agent and will promptly amend or supplement, at its own expense, such Permitted Free Writing
Prospectus to eliminate or correct such conflict, untrue statement or omission.


 




    	21



    	 



    

 


(d)          The
Company shall use commercially reasonable efforts to take or cause to be taken all necessary action to qualify the Shares for sale
under the securities laws of such jurisdictions as Agent reasonably designates and to continue such qualifications in effect so
long as required for the distribution of the Shares, except that the Company shall not be required in connection therewith to qualify
as a foreign corporation or to execute a general consent to service of process in any state. The Company shall promptly advise
the Agent of the receipt by the Company of any notification with respect to the suspension of the qualification of the Shares for
offer or sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose.


 


(e)          The
Company will furnish to the Agent and counsel for the Agent, to the extent requested, copies of the Registration Statement, the
Base Prospectus, the Prospectus, any Permitted Free Writing Prospectus, and all amendments and supplements to such documents, in
each case as soon as available and in such quantities as the Agent may from time to time reasonably request.


 


(f)          The
Company will make generally available to its security holders as soon as practicable an earnings statement (which need not be audited)
covering a 12-month period that shall satisfy the provisions of Section 11(a) of the Securities Act and Rule 158 of the Rules and
Regulations. If the Company makes any public announcement or release disclosing its results of operations or financial condition
for a completed quarterly or annual fiscal period (each, an “Earnings Release”) and the Company has not
yet filed an Annual Report on Form 10-K or a Quarterly Report on Form 10-Q or a Form 8-K with respect to such information, as applicable,
then, prior to any sale of Shares, the Company shall be obligated to (x) file a prospectus supplement with the Commission under
the applicable paragraph of Rule 424(b), which prospectus supplement shall include the applicable financial information or (y)
file a Report on Form 8-K, which Form 8-K shall include the applicable financial information.


 




    	22



    	 



    

 


(g)          The
Company, whether or not the transactions contemplated hereunder are consummated or this Agreement is terminated, will pay or cause
to be paid (i) all expenses (including stock or transfer taxes and stamp or similar duties allocated to the respective transferees)
incurred in connection with the registration, issue, sale and delivery of the Shares, (ii) all reasonable expenses and fees (including,
without limitation, fees and expenses of the Company’s accountants and counsel) in connection with the preparation, printing,
filing, delivery, and shipping of the Registration Statement (including the financial statements therein and all amendments, schedules,
and exhibits thereto), the Base Prospectus, each Prospectus, any Permitted Free Writing Prospectus, and any amendment thereof or
supplement thereto, and the producing, word-processing, printing, delivery, and shipping of this Agreement and other closing documents,
including Blue Sky Memoranda (covering the states and other applicable jurisdictions) and including the cost to furnish copies
of each thereof to the Agent, (iii) all filing fees, (iv) listing fees, if any, (v) the cost and expenses of the Company relating
to investor presentations or any “roadshow” undertaken in connection with marketing of the Shares as agreed to by the
Company, and (vi) all other costs and expenses of the Company incident to the performance of its obligations hereunder that are
not otherwise specifically provided for herein. The Company has advanced the sum of $25,000 to the Agent, which pursuant to Rule
5110(f)(2)(C) of the Financial Industry Regulatory Authority, Inc. (“FINRA”) shall be returned to the
Company in the event that the offering is terminated and to the extent the expenses have not been actually incurred. In addition,
upon execution of this Agreement, the Company shall reimburse the Agent upon request for its reasonable costs and out-of-pocket
expenses incurred in connection with this Agreement, including the fees and disbursements of its legal counsel, not to exceed $75,000.
Furthermore, the Company shall reimburse the Agent upon its request for its reasonable costs and out-of-pocket expenses incurred
in connection with a Bringdown Date (as defined in Section 4(q) below), including the fees and disbursement of its legal counsel,
not to exceed $7,500 in connection with each Bringdown Date. All such reimbursements under this Agreement shall be paid in U.S.
dollars. The Company shall bear and be responsible for all expenses which are customarily borne by issuers for transactions of
the type set forth herein.


 


(h)          The
Company will apply the net proceeds from the sale of the Shares in the manner set forth under the caption “Use of Proceeds”
in the Base Prospectus, the Prospectus, and any Permitted Free Writing Prospectus.


 


(i)          The
Company will not offer for sale, sell, contract to sell, pledge, grant any option for the sale of, enter into any transaction which
is designed to, or might reasonably be expected to, result in the disposition (whether by actual disposition or effective economic
disposition due to cash settlement or otherwise) by the Company or any Subsidiary, or otherwise issue or dispose of, directly or
indirectly (or publicly disclose the intention to make any such offer, sale, pledge, grant, issuance or other disposition), of
any Ordinary Shares or any securities convertible into or exchangeable for, or any options or rights to purchase or acquire, Ordinary
Shares, or permit the registration under the Securities Act of any Ordinary Shares, such securities, options or rights, except
for (i) the registration of the Shares and the sales through the Agent pursuant to this Agreement (ii) the registration of Ordinary
Shares issued or issuable with respect to any currently outstanding options and warrants that are described in the Registration
Statement and the Prospectus, (iii) a registration statement on Form S-8 relating to employee benefit plans and (iv) the issuance
of Ordinary Shares in connection with a bona fide acquisition from a third party, and (v) the issuance of Ordinary Shares in any
private placement(s).


 


(j)          The
Company shall not, at any time at or after the execution of this Agreement, offer or sell any Shares by means of any “prospectus”
(within the meaning of the Securities Act), or use any “prospectus” (within the meaning of the Securities Act) in connection
with the offer or sale of the Shares, in each case other than the Prospectus or any Permitted Free Writing Prospectus.


 


(k)          The
Company has not taken and will not take, directly or indirectly, any action designed to or which might reasonably be expected to
cause or result in, or which has constituted, (i) the stabilization or manipulation of the price of any security of the Company
to facilitate the sale or resale of the Shares or (ii) a violation of Regulation M. The Company shall notify the Agent of any violation
of Regulation M by the Company or any of its officers or directors promptly after the Company has received notice or obtained knowledge
of any such violation.


 




    	23



    	 



    

 


(l)          The
Company will not incur any liability for any finder’s or broker’s fee or agent’s commission in connection with
the execution and delivery of this Agreement or the consummation of the transactions contemplated hereby or thereby.


 


(m)          During
any applicable Prospectus Delivery Period, the Company will file on a timely basis with the Commission such periodic and current
reports as required by the Rules and Regulations.


 


(n)          Except
as described in the Company’s annual report on Form 10-K for the fiscal year ended June 30, 2014, the Company has maintained,
and will maintain, such controls and procedures, including without limitation those required by Sections 302 and 906 of the Sarbanes-Oxley
Act and the applicable regulations thereunder, that are designed to ensure that information required to be disclosed by the Company
in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time
periods specified in the Commission’s rules and forms, including without limitation, controls and procedures designed to
ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act
is accumulated and communicated to the Company’s management, including its principal executive officer and its principal
financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure,
to ensure that material information relating to Company is made known to them by others within those entities.


 


(o)          If
the Company consummates any public of private offering or other financing or capital raising transaction of any kind (a “Subsequent
Financing”) at any time within the twelve month period following the expiration or termination of this Agreement,
to the extent that such financing or capital is provided to the Company by investors introduced directly or indirectly to the Company
by the Agent, the Agent shall be entitled to receive as a fee 3.5% of the gross proceeds received by the Company from such investors.


 


(p)          Each
of the Company and Agent represent and agree that, neither the Company nor the Agent has made and will make any offer relating
to the Shares that would constitute an “issuer free writing prospectus,” as defined in Rule 433 under the Securities
Act, or that would otherwise constitute a “free writing prospectus,” as defined in Rule 405 under the Securities Act,
required to be filed with the Commission other than a Permitted Free Writing Prospectus. The Company represents that it has treated
or agrees that it will treat each Permitted Free Writing Prospectus as an “issuer free writing prospectus,” as defined
in Rule 433, and has complied and will comply with the requirements of Rule 433 applicable to any Permitted Free Writing Prospectus,
including timely Commission filing where required, legending and record keeping.


 




    	24



    	 



    

 


(q)          On
the date hereof and each date when the Company (A) amends or supplements (other than a supplement to a Prospectus filed pursuant
to Rule 424(b) under the Securities Act relating solely to the offering of securities other than the Shares ) the Registration
Statement or Prospectus by means of a post-effective amendment, sticker, or supplement but not by means of incorporation of documents
by reference into the Registration Statement or the Prospectus relating to the Shares, (B) files an annual report on Form 10-K
under the Exchange Act (including any Form 10-K/A containing amended material financial information or a material amendment to
the previously filed Form 10-K), (C) files a quarterly report on Form 10-Q under the Exchange Act (including any Form 10-Q/A containing
amended material financial information or a material amendment to the previously filed Form 10-Q) or (D) files a current report
on Form 8-K containing financial information that is incorporated by reference in the Registration Statement and Prospectus (each
of the dates in (A) through (D) are referred to herein as a “Bringdown Date”), the Company shall cause
(X) Ellenoff Grossman & Schole LLP, New York counsel for the Company, to furnish to the Agent its written opinion and negative
assurance letter, in form and substance stating in effect the matters set forth on Annex A-1 hereto, (Y) Campbells, Cayman
Islands counsel for the Company to furnish to the Agent its written opinion and negative assurance letter, in form and substance
stating in effect the matters set forth on Annex A-2 and (Z) Jingtian & Gongcheng, PRC counsel for the Company, to furnish
to the Agent its written opinion in form and substance stating in effect the matters set forth on Annex A-3 hereto, each
dated as of a date within ten (10) days after the applicable Bringdown Date, addressed to the Agent and modified as necessary to
relate to the Registration Statement and the Prospectus as amended and supplemented to the time of delivery of such opinions. With
respect to this Section 4(q), in lieu of delivering such opinions or letters for Bringdown Dates subsequent to the date
hereof, such counsel may furnish agent with a letter (a “Reliance Letter”) to the effect that Agent may
rely upon a prior opinion or letter delivered under this Section 4(q) to the same extent as if it were dated the date of
such letter (except that statement in such prior opinion shall be deemed to relate to the Registration Statement and the Prospectus
as amended or supplemented as of such Reliance Letter).


 


Provided, however, the requirement to provide
opinions and letters under this Section 4(q) is hereby waived for any Bringdown Date occurring at a time at which no Transaction
Notice is pending, which waiver shall continue until the earlier to occur of the date the Company delivers a Transaction Notice
hereunder and the next occurring Bringdown Date. Notwithstanding the foregoing, if the Company subsequently decides to sell Shares
following a Bringdown Date when the Company relied on such waiver and did not provide Agent with opinions and letters under this
Section 4(q), then before the Company delivers the Transaction Notice or Agent sells any Shares, the Company shall cause
each of Ellenoff Grossman & Schole LLP, Campbells and Jingtian & Gongcheng to furnish to the Agent a written opinion and
negative assurance letter dated the date of the Transaction Notice.


 


(r)          On
the date hereof, and each date when the Company files an annual report on Form 10-K, or a quarterly report on Form 10-Q, the Company
shall cause Friedman LLP, or other independent accountants satisfactory to the Agent, to deliver to the Agent (x) a letter, dated
as of a date within ten (10) days after such date and addressed to Agent, in form and substance satisfactory to Agent (the first
such letter, the “Initial Comfort Letter”), confirming that they are independent public accountants within
the meaning of the Securities Act and are in compliance with the applicable requirements relating to the qualifications of accountants
under Rule 2-01 of Regulation S-X of the Commission, and stating the conclusions and findings of said firm with respect to the
financial information and other matters and (y) a letter updating the Initial Comfort Letter with any information that would have
been included in the Initial Comfort Letter had it been given on such date and as modified as necessary to relate to the date of
such letter (each such letter, a “Bringdown Comfort Letter”).


 




    	25



    	 



    

 


Provided, however, the requirement to provide
a Bringdown Comfort Letter under this Section 4(r) is hereby waived for any Bringdown Date occurring at a time at which
no Transaction Notice is pending, which waiver shall continue until the earlier to occur of the date the Company delivers a Transaction
Notice hereunder and the next occurring Bringdown Date. Notwithstanding the foregoing, if the Company subsequently decides to sell
Shares following a Bringdown Date when the Company relied on such waiver and did not provide Agent with a Bringdown Comfort Letter
under this Section 4(r), then before the Company delivers the Transaction Notice or Agent sells any Shares, the Company
shall cause Friedman LLP, or other independent accountants satisfactory to the Agent, to deliver to the Agent a Bringdown Comfort
Letter dated the date of the Transaction Notice.


 


(s)          On
the date hereof and each Bringdown Date, the Company shall furnish to the Agent a certificate, dated as of a date within ten (10)
days after the applicable Bringdown Date and addressed to Agent, signed by the chief executive officer and by the chief financial
officer of the Company, to the effect that:


 


(i)          The
representations and warranties of the Company in this Agreement are true and correct in all material respects as if made at and
as of the date of the certificate, and the Company has complied in all material respects with all the agreements and satisfied
all the conditions on its part to be performed or satisfied at or prior to the date of the certificate;


 


(ii)         No
stop order or other order suspending the effectiveness of the Registration Statement or any part thereof or any amendment thereof
or the qualification of the Shares for offering or sale or notice that would prevent use of the Registration Statement, nor suspending
or preventing the use of the Base Prospectus, the Prospectus or any Permitted Free Writing Prospectus, has been issued, and no
proceeding for that purpose has been instituted or, to the best of their knowledge, is contemplated by the Commission or any state
or regulatory body;


 


(iii)        The
Shares to be sold on that date have been duly and validly authorized by the Company and that all corporate action required to be
taken for the authorization, issuance and sale of the Shares on that date has been validly and sufficiently taken;


 


(iv)        Subsequent
to the respective dates as of which information is given in the Base Prospectus, the Prospectus or any Permitted Free Writing Prospectus,
as amended and supplemented, and except for pending transactions disclosed therein, the Company has not incurred any material liabilities
or obligations, direct or contingent, or entered into any material transactions, not in the ordinary course of business, or declared
or paid any dividends or made any distribution of any kind with respect to its capital stock, and there has not been any change
in the capital stock or any issuance of options, warrants, convertible securities or other rights to purchase the capital stock
(other than as a result of the exercise of any currently outstanding options or warrants that are disclosed in the Prospectus),
or any material change in the short-term or long-term debt, of the Company, or any Material Adverse Effect or any development that
would reasonably be likely to result in a Material Adverse Effect (whether or not arising in the ordinary course of business),
or any material loss by strike, fire, flood, earthquake, accident or other calamity, whether or not covered by insurance, incurred
by the Company; and


 




    	26



    	 



    

 


(v)         Except
as stated in the Base Prospectus, the Prospectus, and any Permitted Free Writing Prospectus, as amended and supplemented, there
is not pending, or, to the knowledge of the Company, threatened or contemplated, any action, suit or proceeding to which the Company
is a party before or by any court or governmental agency, authority or body, or any arbitrator, which would reasonably be likely
to result in any Material Adverse Effect;


 


provided, however, the requirement to provide a certificate under
this Section 4(s) is hereby waived for any Bringdown Date occurring at a time at which no Transaction Notice is pending,
which waiver shall continue until the earlier to occur of the date the Company delivers a Transaction Notice hereunder and the
next occurring Bringdown Date. Notwithstanding the foregoing, if the Company subsequently decides to sell Shares following a Bringdown
Date when the Company relied on such waiver and did not provide Agent with a certificate under this Section 4(r), then before
the Company delivers the Transaction Notice or Agent sells any Shares, the Company shall provide Agent with a certificate dated
the date of the Transaction Notice.


 


(t)          A
reasonable time prior to each Bringdown Date, the Company, if so requested by the Agent, shall conduct a due diligence session,
in form and substance, satisfactory to the Agent, which shall include representatives of the management and the accountants of
the Company.


 


(u)          The
Company shall disclose in its annual report on Form 10-K and its quarterly reports on Form 10-Q the number of Shares sold through
the Agent under this Agreement, the Net Proceeds to the Company and the compensation paid by the Company with respect to sales
of the Shares pursuant to this Agreement and, at least once a quarter and subject to Section 4(a) above, file a prospectus supplement
containing such information pursuant to Rule 424(b) under the Securities Act.


 


(v)         The
Company shall ensure that there are at all times sufficient Ordinary Shares to provide for the issuance, free of any preemptive
rights, out of its authorized but unissued Ordinary Shares, of the maximum aggregate number of Shares authorized for issuance by
the Board pursuant to the terms of this Agreement. The Company will use its reasonable best efforts to cause the Shares to be listed
on the NASDAQ Capital Market, and to maintain such listing. The Company shall cooperate with Agent and use its reasonable efforts
to permit Shares to be eligible for clearance and settlement through the facilities of DTC.


 


(w)          At
any time during the term of this Agreement, the Company will advise the Agent promptly after it receives notice or obtains knowledge
of any information or fact that would alter or affect any opinion, certificate, letter and other document provided to the Agent
pursuant to Section 4 herein.


 


(x)          Subject
to compliance with any applicable requirements of Regulation M under the Exchange Act and compliance with applicable securities
laws, the Company consents to the Agent trading in Ordinary Shares for the Agent’s own account and for the account of its
clients (in compliance with all applicable laws) at the same time as sales of the Shares occur pursuant to this Agreement.


 




    	27



    	 



    

 


(y)          If
to the knowledge of the Company, any condition set forth in Section 5(a) or 5(b) of this Agreement shall not have
been satisfied on the applicable Settlement Date, the Company will offer to any person who has agreed to purchase the Shares on
such Settlement Date from the Company as the result of an offer to purchase solicited by the Agent the right to refuse to purchase
and pay for such Shares.


 


(z)          On
the date hereof and each Bringdown Date, the Company shall furnish to the Agent an incumbency certificate, dated as of such date
and addressed to Agent, signed by the secretary of the Company.


 


5.           Conditions
of Agent’s Obligations. The obligations of the Agent hereunder are subject to (i) the accuracy of, as of the date
hereof, each Bringdown Date, and each Time of Sale (in each case, as if made at such date), and compliance with, all representations,
warranties and agreements of the Company contained herein, (ii) the performance by the Company of its obligations hereunder and
(iii) the following additional conditions:


 


(a)          If
filing of the Prospectus, or any amendment or supplement thereto, or any Permitted Free Writing Prospectus, is required under the
Securities Act or the Rules and Regulations, the Company shall have filed the Prospectus (or such amendment or supplement) or such
Permitted Free Writing Prospectus with the Commission in the manner and within the time period so required (without reliance on
Rule 424(b)(8) or Rule 164(b)); the Registration Statement shall remain effective; no stop order suspending the effectiveness of
the Registration Statement or any part thereof, any Rule 462(b) Registration Statement, or any amendment thereof, nor suspending
or preventing the use of the Base Prospectus, the Prospectus or any Permitted Free Writing Prospectus shall have been issued; no
proceedings for the issuance of such an order shall have been initiated or threatened; and any request of the Commission for additional
information (to be included in the Registration Statement, the Base Prospectus, the Prospectus, any Permitted Free Writing Prospectus
or otherwise) shall have been complied with to the Agent’s satisfaction.


 


(b)          The
Agent shall not have advised the Company that the Registration Statement, the Base Prospectus, the Prospectus, or any amendment
or supplement thereto, or any Permitted Free Writing Prospectus, contains an untrue statement of fact which, in the Agent’s
opinion, is material, or omits to state a fact which, in the Agent’s opinion, is material and is required to be stated therein
or is necessary to make the statements therein (i) with respect to the Registration Statement, not misleading and (ii) with respect
to the Base Prospectus, the Prospectus or any Permitted Free Writing Prospectus, in light of the circumstances under which they
were made, not misleading.


 


(c)          Except
as set forth or contemplated in the Base Prospectus, the Prospectus and any Permitted Free Writing Prospectus, subsequent to the
respective dates as of which information is given therein, the Company shall not have incurred any material liabilities or obligations,
direct or contingent, or entered into any material transactions, or declared or paid any dividends or made any distribution of
any kind with respect to its capital stock and there shall not have been any change in the capital stock, or any issuance of options,
warrants, convertible securities or other rights to purchase the capital stock (other than as a result of the exercise of any currently
outstanding options or warrants that are disclosed in the Prospectus), or any material change in the short-term or long-term debt,
of the Company, or any Material Adverse Effect or any development that would be reasonably likely to result in a Material Adverse
Effect (whether or not arising in the ordinary course of business), or any material loss by strike, fire, flood, earthquake, accident
or other calamity, whether or not covered by insurance, incurred by the Company, the effect of which, in any such case described
above, in the Agent’s judgment, makes it impractical or inadvisable to offer or deliver the Shares.


 




    	28



    	 



    

 


(d)          The
Company shall have performed each of its obligations under Section 4(q).


 


(e)          The
Company shall have performed each of its obligations under Section 4(r).


 


(f)          The
Company shall have performed each of its obligations under Section 4(s).


 


(g)          The
Financial Industry Regulatory Authority, Inc. shall have raised no objection to the fairness and reasonableness of the underwriting
terms and arrangements.


 


(h)          All
filings with the Commission required by Rule 424 under the Securities Act to have been filed by the Settlement Date shall have
been made within the applicable time period prescribed for such filing by Rule 424.


 


(i)          The
Company shall have furnished to Agent and the Agent’s counsel such additional documents, certificates and evidence as they
may have reasonably requested.


 


(j)          Trading
in the Common Stock shall not have been suspended on the NASDAQ Capital Market. The Shares shall have been listed and authorized
for trading on the NASDAQ Capital Market, and satisfactory evidence of such actions shall have been provided to the Agent and its
counsel, which may include oral confirmation from a representative of the NASDAQ Capital Market.


 


All such opinions, certificates, letters and other
documents will be in compliance with the provisions hereof only if they are reasonably satisfactory in form and substance to Agent
and the Agent’s counsel. The Company will furnish Agent with such conformed copies of such opinions, certificates, letters
and other documents as Agent shall reasonably request.


 




    	29



    	 



    

 


6.           Indemnification
and Contribution.


 


(a)          (i)          The
Company agrees to indemnify and hold harmless the Agent and each of the other Indemnified Parties (as defined below) from and against
any losses, claims, damages, obligations, penalties, judgments, awards, liabilities, costs, expenses and disbursements, and any
and all actions suits proceedings and investigations in respect thereof and any and all legal and other costs, expenses and disbursements
in giving testimony or furnishing documents in response to subpoena or otherwise (including, without limitation, the costs, expenses
and disbursements, as and when incurred, of investigating, preparing, pursuing or defending any such action, suit, proceeding or
investigation (whether or not in connection with litigation in which any Indemnified Party is a party)) (collectively, “Losses”),
directly or indirectly, caused by, relating to, based upon, arising out of , or in connection with this Agreement, including, without
limitation, any act or omission by the Agent in connection with its acceptance of or the performance or non-performance of its
obligations under the Agreement, any breach by the Company of any representation, warranty, covenant or agreement contained in
the Agreement (or in any instrument, document or agreement relating thereto, including any agency agreement), or the enforcement
by the Agent of its rights under the Agreement or these indemnification provisions, except to the extent that any such Losses are
found in a final judgment by a court of competent jurisdiction (not subject to further appeal) to have resulted primarily and directly
from the gross negligence or willful misconduct of the Indemnified Party seeking indemnification hereunder. The Company also agrees
that no Indemnified Party shall have any liability (whether direct or indirect, in contract or tort or otherwise) to the Company
for or in connection with this Agreement for any other reason, except to the extent that any such liability is found in a final
judgment by a court of competent jurisdiction (not subject to further appeal) to have resulted primarily and directly from such
Indemnified Party’s gross negligence or willful misconduct This indemnity agreement will be in addition to any liability
that the Company otherwise might have.


 


(ii)         These
indemnification provisions shall extend to the following persons (collectively, the “Indemnified Parties”):
Maxim, its present and former affiliated entities, managers, members, officers, employees, legal counsel, agents and controlling
persons (within the meaning of the federal securities laws), and the officers, directors, partners, stockholders, members, managers,
employees, legal counsel, agents and controlling persons of any of them. These indemnification provisions shall be in addition
to any liability which the Company may otherwise have to any Indemnified Party.


 


(iii)        If
any action, suit, proceeding or investigation is commenced, as to which an Indemnified Party proposes to demand indemnification,
it shall notify the Company with reasonable promptness; provided, however, that any failure by an Indemnified Party
to notify the Company shall not relieve the Company from its obligations hereunder except to the extent that the Company is actually
and materially prejudiced by such failure to notify. An Indemnified Party shall have the right to retain counsel of its own choice
to represent it, and the fees, expenses and disbursements of such counsel shall be borne by the Company. Any such counsel shall,
to the extent consistent with its professional responsibilities, cooperate with the Company and any counsel designated by the Company.
The Company shall be liable for any settlement of any claim against any Indemnified Party made with the Company’s written
consent. The Company shall not, without the prior written consent of the Agent, settle or compromise any claim, or permit a default
or consent to the entry of any judgment in respect thereof, unless such settlement, compromise or consent (i) includes, as an unconditional
term thereof, the giving by the claimant to all of the Indemnified Parties of an unconditional release from all liability in respect
of such claim, and (ii) does not contain any factual or legal admission by or with respect to an Indemnified Party or an adverse
statement with respect to the character, professionalism, expertise or reputation of any Indemnified Party or any action or inaction
of any Indemnified Party.


 




    	30



    	 



    

 


(iv)        In
order to provide for just and equitable contribution, if a claim for indemnification pursuant to these indemnification provisions
is made but it is found in a final judgment by a court of competent jurisdiction (not subject to further appeal) that such indemnification
may not be enforced in such case, even though the express provisions hereof provide for indemnification in such case, then the
Company shall contribute to the Losses to which any Indemnified Party may be subject (i) in accordance with the relative benefits
received by the Company and its stockholders, subsidiaries and affiliates, on the one hand, and the Indemnified Party, on the other
hand, and (ii) if (and only if) the allocation provided in clause (i) of this sentence is not permitted by applicable law, in such
proportion as to reflect not only the relative benefits, but also the relative fault of the Company, on the one hand, and the Indemnified
Party, on the other hand, in connection with the statements, acts or omissions which resulted in such Losses as well as any relevant
equitable considerations. No person found liable for a fraudulent misrepresentation shall be entitled to contribution from any
person who is not also found liable for fraudulent misrepresentation. The relative benefits received (or anticipated to be received)
by the Company and its stockholders, subsidiaries and affiliates shall be deemed to be equal to the aggregate consideration payable
or receivable by such parties in connection with the transaction or transactions to which the Agreement relates relative to the
amount of fees actually received by the Agent in connection with such transaction or transactions. Notwithstanding the foregoing,
in no event shall the amount contributed by all Indemnified Parties exceed the amount of fees previously received by the Agent
pursuant to the Agreement.


 


(b)          (i)          The
Agent will indemnify and hold harmless the Company and its affiliates and directors and each officer of the Company who signed
the Registration Statement and each person, if any, who controls the Company within the meaning of Section 15 of the Securities
Act or Section 20 of the Exchange Act (the “Company Indemnified Parties”) from and against any Losses
to which the Company or the Company Indemnified Parties may become subject, under the Securities Act or otherwise (including in
settlement of any litigation, if such settlement is effected with the written consent of the Agent), insofar as such losses, claims,
damages or liabilities (or actions in respect thereof) arise out of or are based upon an untrue statement or omission or alleged
untrue statement or omission of a material fact contained in the Registration Statement, any Base Prospectus, the Prospectus, or
any amendment or supplement thereto or any Permitted Free Writing Prospectus, to the extent, that such untrue statement or alleged
untrue statement or omission or alleged omission was made in the Registration Statement, any Base Prospectus, the Prospectus, or
any amendment or supplement thereto, or any Permitted Free Writing Prospectus in reliance upon and in conformity with written information
furnished to the Company by Agent expressly for use in the preparation thereof, it being understood and agreed that the only information
furnished by the Agent consists of the information described as such in Section 6(b)(ii) hereof, by the Company in connection
with investigating or defending against any such loss, claim, damage, liability or action.


 


(ii)         The
Agent confirms and the Company acknowledges that as of the date hereof no information has been furnished in writing to the Company
by or on behalf of the Agent specifically for inclusion in the Registration Statement, any Base Prospectus, the Prospectus or any
Permitted Free Writing Prospectus.


 




    	31



    	 



    




 


(c)          If
the indemnification provided for in this Section 6 is unavailable or insufficient to hold harmless an indemnified party
under subsection (a) or (b) above, then each indemnifying party shall contribute to the amount paid or payable by such indemnified
party as a result of the losses, claims, damages or liabilities referred to in subsection (a) or (b) above, (i) in such proportion
as is appropriate to reflect the relative benefits received by the Company on the one hand and the Agent on the other from the
Offering or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, in such proportion as is appropriate
to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the Company on the one
hand and the Agent on the other in connection with the statements or omissions that resulted in such losses, claims, damages or
liabilities, as well as any other relevant equitable considerations. The relative benefits received by the Company on the one hand
and the Agent on the other shall be deemed to be in the same proportion as the total net proceeds from the Offering (before deducting
expenses) received by the Company and the total underwriting discounts and commissions received by the Agent, bear to the total
public offering price of the Shares. The relative fault shall be determined by reference to, among other things, whether the untrue
or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information
supplied by the Company or the Agent and the parties’ relevant intent, knowledge, access to information and opportunity to
correct or prevent such untrue statement or omission. The Company and the Agent agree that it would not be just and equitable if
contributions pursuant to this subsection (e) were to be determined by pro rata allocation or by any other method of allocation
which does not take account of the equitable considerations referred to in the first sentence of this subsection (e). The amount
paid by an indemnified party as a result of the losses, claims, damages or liabilities referred to in the first sentence of this
subsection (e) shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in connection
with investigating or defending against any action or claim which is the subject of this subsection (e). Notwithstanding the provisions
of this subsection (e), the Agent shall not be required to contribute any amount in excess of the amount by which the total price
at which the Shares underwritten by it and distributed to the public were offered to the public exceeds the amount of any damages
that the Agent has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission.
No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled
to contribution from any person who was not guilty of such fraudulent misrepresentation.


 


(d)          Neither
termination of this Agreement nor completion of the Offering shall affect these indemnification provisions which shall remain operative
and in full force and effect. The indemnification provisions shall be binding upon the Company and the Agent and their respective
successors and assigns and shall inure to the benefit of the Indemnified Parties and the Company Indemnified Parties and their
respective successors, assigns, heirs and personal representatives.


 


7.           Representations
and Agreements to Survive Delivery. All representations and warranties of the Company herein or in certificates delivered
pursuant hereto, and agreements of the Agent and the Company herein, including but not limited to the agreements of the Agent and
the Company contained in Section 6 hereof, shall remain operative and in full force and effect regardless of any investigation
made by or on behalf of the Agent or any controlling person thereof, or the Company or any of its officers, directors, or controlling
persons, and shall survive delivery of, and payment for, the Shares to and by the Agent hereunder.


 




    	32



    	 



    

 


8.           Termination
of this Agreement.


 


(a)          The
Company shall have the right, by giving a 15 day prior written notice as hereinafter specified, to terminate this Agreement in
its sole discretion at any time. Any such termination shall be without liability of any party to any other party except that (i)
if the Shares have been sold through the Agent for the Company, then Sections 4(g), 4(o) and 4(y) shall remain
in full force and effect, (ii) with respect to any pending sale, through the Agent for the Company, the obligations of the Company
with respect to such pending sale of Shares, including in respect of compensation of the Agent, shall remain in full force and
effect notwithstanding such termination and (iii) the provisions of Section 4(g), Section 4(o), Section 6
and Section 7 of this Agreement shall remain in full force and effect notwithstanding such termination.


 


(b)          The
Agent shall have the right, by giving written notice as hereinafter specified, to terminate the provisions of this Agreement relating
to the solicitation of offers to purchase the Shares in its sole discretion at any time. Any such termination shall be without
liability of any party to any other party except that (i) the provisions of the last three sentences of Section 4(g) and
the entirety of Section 4(o), Section 6 and Section 7 of this Agreement shall remain in full force and effect
notwithstanding such termination and (ii) the provisions of Section 4(g) other than the last three sentences thereof shall
remain in full force and effect only if the Agent has terminated this Agreement as a result of the Company’s default of its
obligations hereunder and its failure to cure any default within a reasonable period of time.


 


(c)          This
Agreement shall remain in full force and effect unless terminated pursuant to Sections 8(a) or (b) above or otherwise
by mutual agreement of the parties; provided that any such termination by mutual agreement shall in all cases be deemed to provide
that Section 4(g), Section 4(o), Section 6 and Section 7 shall remain in full force and effect. This
Agreement shall terminate automatically upon the issuance and sale of Shares having an aggregate offering price equal to the amount
set forth in the first paragraph of this Agreement.


 


(d)          Any
termination of this Agreement shall be effective on the date specified in such notice of termination; provided that such termination
shall not be effective earlier than 15 days after the close of business on the date of receipt of such notice by the Agent or the
close of business on the date of receipt of such notice by the Company, as the case may be. If such termination shall occur prior
to the Settlement Date for any sale of the Shares, such sale shall settle in accordance with the provisions of Section 3(a)(vi)
of this Agreement.


 


9.           Default
by the Company. If the Company shall fail at any Settlement Date to sell and deliver the number of Shares which it is obligated
to sell hereunder, then this Agreement shall terminate without any liability on the part of the Agent or, except as provided in
Section 4(g) hereof, any non-defaulting party. No action taken pursuant to this Section 9 shall relieve the Company
from liability, if any, in respect of such default, and the Company shall (A) hold the Agent harmless against any loss, claim or
damage arising from or as a result of such default by the Company and (B) pay the Agent any commission to which it would otherwise
be entitled absent such default.


 




    	33



    	 



    

 


10.          Notices.
Except as otherwise provided herein, all communications under this Agreement shall be in writing and, if to the Agent, shall be
mailed, delivered or telecopied to Maxim Group LLC, 405 Lexington Avenue, New York, New York 10174, (fax: (212) 895-3783), Attention:
Clifford A. Teller, Executive Managing Director of Global Investment Banking, with a required copy (which shall not constitute
notice) to Loeb & Loeb LLP, 345 Park Avenue, New York, New York 10154 (fax: (212) 407-4990) Attention: Mitchell S. Nussbaum,
Esq. Notices to the Company shall be given to it at 1902 Building C, King Long International Mansion, No. 9 Fulin Road, Beijing
100107 China (fax:_____________ ) Attention: Shenping Yin, with required copies (which shall not constitute notice) to Ellenoff
Grossman & Schole 1345 Avenue of the Americas, New York, NY 10105 (fax: (212)370-7889) Attention: Barry Grossman. Any party
to this Agreement may change such address for notices by sending to the parties to this Agreement written notice of a new address
for such purpose.


 


11.          Persons
Entitled to Benefit of Agreement. This Agreement shall inure to the benefit of and be binding upon the parties hereto and
their respective successors and assigns and the controlling persons, officers and directors referred to in Section 6. Nothing in
this Agreement is intended or shall be construed to give to any other person, firm or corporation any legal or equitable remedy
or claim under or in respect of this Agreement or any provision herein contained. The term “successors and assigns”
as herein used shall not include any purchaser, as such purchaser, of any of the Shares from the Agent.


 


12.          Absence
of Fiduciary Relationship. The Company acknowledges and agrees that: (a) the Agent has been retained solely to act as an
sales agent and/or principal in connection with the sale of the Shares and that no fiduciary, advisory or agency relationship between
the Company and the Agent has been created in respect of any of the transactions contemplated by this Agreement, irrespective of
whether the Agent has advised or are advising the Company on other matters; (b) the price and other terms of the Shares set forth
in this Agreement were established by the Company following discussions and arms-length negotiations with the Agent and the Company
is capable of evaluating and understanding and understands and accepts the terms, risks and conditions of the transactions contemplated
by this Agreement; (c) it has been advised that the Agent and its affiliates are engaged in a broad range of transactions which
may involve interests that differ from those of the Company and that the Agent has no obligation to disclose such interest and
transactions to the Company by virtue of any fiduciary, advisory or agency relationship; (d) it has been advised that the Agent
is acting, in respect of the transactions contemplated by this Agreement, solely for the benefit of the Agent, and not on behalf
of the Company; and (e) it waives to the fullest extent permitted by law, any claims it may have against the Agent for breach of
fiduciary duty or alleged breach of fiduciary duty in respect of any of the transactions contemplated by this Agreement and agrees
that the Agent shall have no liability (whether direct or indirect) to the Company in respect of such a fiduciary duty claim on
behalf of or in right of the Company, including stockholders, employees or creditors of the Company.


 


13.          Governing
Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York, including
Section 5-1401 of the General Obligations Law of the State of New York, but otherwise without regard to conflict of laws rules
that would apply the laws of any other jurisdiction.


 


14.          Counterparts.
This Agreement may be executed in one or more counterparts and, if executed in more than one counterpart, the executed counterparts
shall each be deemed to be an original and all such counterparts shall together constitute one and the same instrument.


 




    	34



    	 



    

 


15.          Adjustments
for Stock Splits. The parties acknowledge and agree that all share-related numbers contained in this Agreement shall be
adjusted to take into account any stock split, stock dividend or similar event effected with respect to the Shares.


 


16.         Entire
Agreement; Amendment; Severability. This Agreement (including all schedules and exhibits attached hereto and transaction
notices issued pursuant hereto) constitutes the entire agreement and supersedes all other prior and contemporaneous agreements
and undertakings, both written and oral, among the parties hereto with regard to the subject matter hereof. Neither this Agreement
nor any term hereof may be amended except pursuant to a written instrument executed by the Company and the Agent. In the event
that any one or more of the provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal
or unenforceable as written by a court of competent jurisdiction, then such provision shall be given full force and effect to the
fullest possible extent that it is valid, legal and enforceable, and the remainder of the terms and provisions herein shall be
construed as if such invalid, illegal or unenforceable term or provision was not contained herein, but only to the extent that
giving effect to such provision and the remainder of the terms and provisions hereof shall be in accordance with the intent of
the parties as reflected in this Agreement.


 


17.         Waiver
of Jury Trial. Each of the Company and the Agent hereby waives any right it may have to a trial by jury in respect of any
claim based upon or arising out of this Agreement or the transactions contemplated hereby.


 


Please sign and return to the Company the enclosed
duplicates of this letter whereupon this letter will become a binding agreement between the Company and the Agent in accordance
with its terms.


 


	 	Very truly yours,
	 	 
	 	RECON TECHNOLOGY LTD.
	 	 
	 	By: /s/  Yinping Shen
	 	Name:  Yinping Shen
	 	Title:  Chief Executive Officer


 


Confirmed as of the date first

above mentioned.


 


	MAXIM GROUP LLC	 
	 	 
	By  /s/ Clifford A. Teller	 
	Name:  Clifford A. Teller	 
	Title:  Executive Managing Director,	 
	Head of Investment Banking	 


 




    	35



    	 



    

 


Schedule A


 


Permitted Free Writing Prospectus


 


None.


 




    	Schedule A-1



    	 



    

 


Schedule B


 


Individuals Permitted to Authorize Sales of
Shares


 


Shenping Yin, the Chief Executive Officer of
the Company


 


Jia Liu, Secretary and Chief Financial Officer
of the Company


 




    	Schedule B-1



    	 



    

 


Schedule C


 


Form of E-mail or Telecopy Confirmation


 


From: Recon Technology Ltd.


 


To: Maxim Group LLC


 


Attention:


 


Subject: Transaction Notice


 


Gentlemen:


 


Pursuant to the terms and subject to the conditions
contained in the Equity Distribution Agreement between Maxim Group LLC (“Maxim”) and Recon Technology Ltd. (the
“Company”), dated May 13, 2015, the Company hereby requests that Maxim sell up to of the Company’s ordinary shares,
par value $0.0185 per share, at a minimum market price of $ per share, during the time period beginning [month, day, time] and
ending [month, day, time].


 




    	Schedule C-1



    	 



    

 


Schedule D


 


Individuals to Which Notice Can Be Given


 




    	Schedule D-1



    	 



    

 


Schedule E


 


List of Subsidiaries and VIEs


 


Hong Kong Subsidiary


 


Recon Technology Co., Limited, a Hong Kong corporation


 


PRC Subsidiary


 


Recon Technology (Jining) Co., Ltd., a wholly-owned
foreign enterprise incorporated under the laws of the People’s Republic of China


 


VIEs:


 


Beijing BHD Petroleum Technology Co. Ltd.


 


Nanjing Recon Technology Co., Ltd.


 




    	Schedule E-1



    	 



    

 


ANNEX A-1


 


FORM OF U.S. COUNSEL OPINION


 




    	Annex A-1



    	 



    

 


ANNEX A-2


 


FORM OF CAYMAN ISLANDS COUNSEL OPINION


 




    	Annex A-2



    	 



    

 


ANNEX A-3


 


FORM OF PRC COUNSEL OPINION


 




    	Annex A-3